MDT Medtronic plc

Stock NYSE Healthcare

US$92.63 -1.22% Latest close

Medtronic plc (MDT) trend channel, buy level and 3-month target on Trade The Path. Sector: Healthcare. Listed on NYSE. There is not a clean channel on this listing yet, so we publish no buy/sell numbers and do not index this URL. Quote and company profile remain visible.

No trend channel yet

There is not enough price history for this listing to fit trend lines โ€” it is newly listed, thinly traded, or not yet covered by our data provider. Everything else on this page still works: you can add it to your watchlist and we will fit the channel automatically once enough daily prices have built up. Telegram alerts stay off for this one until then.

Price history

US$80.0US$100.0US$120.0Aug 20June 21Apr 22Feb 23Dec 23Oct 24Aug 25June 26 today
  • Daily close

No trade suggested right now

There is not yet a channel we can put a buy and a target on.

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha
Employees
95,000
Country
IE

https://www.medtronic.com

Scorecard

Our own pillar scores, computed from the fundamentals below. They are not Morningstar ratings โ€” that data is licensed and we do not redistribute it.

Valuation
โ€”
Profitability
โ€”
Financial health
โ€”
Cash generation
โ€”

Key statistics

Market cap
US$120.07B
Enterprise value
โ€”
Beta
0.57
Avg volume
9.10M
Revenue per share
โ€”
Dividend yield
โ€”
52-week range
73.31-106.33
Exchange
NYSE

Key ratios

P/E (TTM)
โ€”
PEG
โ€”
Price / sales
โ€”
Price / book
โ€”
EV / EBITDA
โ€”
Gross margin
โ€”
Operating margin
โ€”
Net margin
โ€”
Current ratio
โ€”
Quick ratio
โ€”
Debt / equity
โ€”
Interest cover
โ€”

Income statement

Balance sheet

Cash flow

Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.